Clinical Trial Update: Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating imatinib treatment in recent-onset type 1 diabetes mellitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: University of California, San Francisco | Conditions: Diabetes Mellitus, Type I, Diabetes Mellitus, Insulin-Dependent, 1 | Phase 2 | Status: COMPLETED | Results posted: 2018-08-08